And, just at the moment when many startup are gaining traction is also when they are most vulnerable to losing their way, to forgetting what they are uniquely about as the VCs try to fit them into a revenue model.
Not just the three or four that I just mentioned, but also to Bactrim - a very commonly-used antibiotic and possibly vancomycin and - I'm forgetting the other one.